have examined the effect of the oral gold compound auranofin (AF) on calcium ionophore A23187-induced arachidonic acid metabolism in the rat alveolar macrophage. Both reverse-phase high performance liquid chromatographic and radioimmunoassay analyses revealed that AF dose-dependently inhibited leukotriene B4 and 5-hydroxyeicosatetraenoic acid synthesis in a parallel fashion with an %I -4.3 pg/ml. At the same time, AF augmented A23187-induced arachidonate release and cyclooxygenase metabolism. A possible mechanism for the inhibition of 5-lipoxygenase was suggested by the capacity of AF to dose-dependently deplete ATP (ICY -5.9 pg/ml), a cofactor for 5-iipoxygenase.
Chrysotherapy has well-established efficacy in the treatment of rheumatoid arthritis [l] . In addition, gold salts have been shown to attenuate airway responsiveness in animals [2] as well as humans [3] , and to decrease symptom scores and medication requirements in patients with asthma [3, 4] . It is generally recognized that chronic inflammation plays a prominent role in the pathogenesis of both rheumatoid arthritis [S] and asthma [6] , and prominent among the many potential mediators of inflammation which have been suggested to be impo~ant in these conditions are the eicosanoids, a group of oxygenated derivatives of arachidonic acid (AA) [7] . Recent studies have demonstrated that auranofin (AF), an oral gold compound, inhibits the synthesis of leukotrienes, potent pro-inflammatory 5-lipoxygenase metabolites of AA, in human blood neutrophils [8, 9] , basophils [lo] , and lung mast cells
WI*
Although the macrophage is thought to play a central role in chronic inflammatory disorders [ll] , has the capacity to release relatively large amounts of cyclooxygenase and 5lipoxygenase eicosanoids 1121, and is a putative target cell for the anti-inflammatory effects of gold 1131, we are aware of no information on the modulation by gold compounds of macrophage-derived eicosanoid synthesis. We therefore examined the effect of AF on calcium ionophore A23187-induced AA metabolism in the rat alveolar macrophage (AM), a cell which produces large amounts of 5lipoxygenase metabolites including both leukotrienes B4 (LTBI) and C4 (LTC3 [14] . Our results indicated that AF inhibits AM 5-lipoxygenase metabolism at therapeutic concen- trations, and they suggest that the mechanism of this inhibitory action may involve the depletion of cellular ATP, a cofactor for the 5-lipoxygenase enzyme [15, 16] .
METHODS
Macrophage isolation and culture. Respiratory disease-free 125-150 g female Wistar rats were obtained from Charles River (Portage, MI) and housed under specific pathogen-free conditions. Follo~ng anesthesia with intrape~toneal sodium pentob~bital, lungs were surgically excised and Iavaged as previously described [17] . Lavage fluid, as well as Hanks' balanced salt solution (HBSS) (GIBCO, Grand Island, NY) and medium 199 with modified Earle's salts (M199) (GIBCO) all contained 100 units/ml penicillin, 100 pg/ml streptomycin, and 0.25 mg/ml amphotericin B (Antibiotic-Antimycotic Solution, Sigma Chemical Co., St. Louis, MO). Cells (2 X 106) suspended in 1.5 ml of Ml99 were plated in 35 x 10 mm plastic culture dishes (Falcon Plastics, Oxnard, CA) and cultured at 37" in a humidified atmosphere of 5% COZ in air. After 1 hr, non-adherent cells were removed by washing twice with HBSS. The resultant adherent cell population has been found to contain 95% AM by morphologic criteria and esterase staining [17] with viability exceeding 90% as assessed by trypan blue exclusion. Macrophage monolayers were then cultured overnight (16 hr) in Ml99 containing 10% heat-inactivated newborn calf serum (NCS) (GIBCO) in the presence or absence of radiolabeled AA prior to experimental incubations.
Following overnight culture, these monolayers have been found to contain approximately 8.5 pg DNA [17] Methanol/ water (80: 20, v/v) eluates containing eicosanoids were dried under nitrogen and stored at -70". Recoveries for this extraction procedure, assessed using tritiated standards (DuPont-New England Nuclear) added to M199, were 65-70% for LTB4, LTC4, and thromboxane Bz (TxBz, the stable breakdown product of TxA2) 1191.
Radioimmunoassays. LTB4, LTC4, and TxBz in medium from unlabeled AM cultures were quantitated by radioimmunoassays (RIA) performed by the Ligand Core Laboratory of the University of Michigan Diabetes Research and Training Center. Dried lipid extracts were dissolved in 1 ml of phosphate-buffered saline containing 0.1% gelatin (pH 7.4), and lOO-~1 aliquots were assayed in duplicate for each sample. The antibody sources and cross-reactivities, and the assay sensitivities for these RIA have been described previously [ 141. The specificities of the RIA have been confirmed by analyses utilizing reverse-phase high performance liquid chromatography (RP-HPLC) 120,211. In all cases, quantities of immunoreactive eicosanoids reported were corrected for recovery.
Eicosanoid separation by reverse-phase high performance liquid chromatography. For separation of [14C]AA metabolites produced by prelabeled AM, lipid extracts of pooled medium from duplicate cultures were dissolved in 500 ~1 of acetonitrile/water/ trifluoroacetic acid (33:67: 0.1, by vol.) and subjected to RP-HPLC using a Waters HPLC system equipped with a Waters 5 pm Bondapak C1s column (30 x 0.4 cm) eluted with acetonitrile/water/ trifluoroacetic acid at 1 ml/min, as previously described [20] . Using this system, cyclooxygenase metabolites are eluted during an initial isocratic phase (33 : 67 : 0.1, by vol.), followed by lipoxygenase metabolites and free AA, which elute during a stepwise gradient increase of acetonitrile to 100 : 0 : 0.1 (by vol.). The eluate was monitored continuously for UV absorbance 1210 nm for cyclooxygenase products and free AA, 280 nm for LTs, and 235 nm for monohydroxyeicosatetraenoic acids (HETEs)]. Authentic TxB2, prostaglandin (PG) Dz, PGE?, PGF2,, and 6-keto-PGF1, were gifts of Dr. J. Pike (Upjohn Co., Kalamazoo, MI), and lipoxygenase standards LTB,, LTC4, 5-HETE, lZHETE, and 15HETE of Dr. J. Rokach (Merck Frosst, Inc., Quebec, Canada). Authentic 12-hydroxy-5.8.10-heptadecatrienoic acid (HHT) was obtained from the Cayman Chemical Co. (Ann Arbor, MI), and arachidonic acid from Nu-Chek Prep, Inc. (Elysian, MN). Eluate fractions of 1 ml were collected, and radioactivity was quantitated in 6 ml of ACS scintillant (Amersham, Arlington Heights, IL) using a Beckman LSl801 scintillation counter (Beckman Instruments, Inc., Fullerton, CA) with a counting efficiency for "C of approximately 75%. Radiolabeled eicosanoids were identified by their co-elution with authentic standards.
Adenosine triphosphate assay. Cellular ATP was determined by the luciferase-luciferin assay [22] , as previously described [ 191. Briefly, after experimental incubation, culture medium was removed and monolayers were scraped with a rubber policeman into iced 10mM potassium phosphate, 4 mM MgSOJ buffer, pH 7.4. Cell suspensions were placed in a 90-95" water bath for 4 min, and then on ice until assay, within 4 hr. At the time of assay, an aliquot of cell suspension was added to 50 mM NazHAs04, 20 mM MgS04 buffer, pH7.4, in a glass scintillation vial. Fifty microliters of luciferase-luciferin (Sigma), reconstituted in sterile glycine buffer. was added to the assay mixture, and light emission was quantitated immediately in a Beckman LS1801 counter using the single photon monitor mode. Standard curves of log cpm versus log [ATP] were linear over the range 1O-9 to lO+'M ATP.
Glutathione assay. Monolayers were deproteinated with 0.7 M perchloric acid, neutralized with 2 iM potassium hydroxide, and intracellular total (reduced plus oxidized) glutathione was quantitated by the glutathione reductase assay ['23] , recording the change in absorbance at 412 nm over time with a Beckman model 35 spe~trophotometer. The details of the cellular processing and of the assay itself were as previously described 1141.
Data analysis. AH data are expressed as means rt SE. In all cases, immunoreactive eicosanoid levels in medium and cellular ATP and glutathione contents were determined in duplicate culture plates for each experimental condition and the average calculated to yield a single data point. The effect of AF on A23187-stimulated eicosanoid synthesis is expressed as the percent of the eicosanoid level found in cultures stimulated with A23187 alone, after correction for control levels of production. Similarly, the effects of AF on cellular content of ATP and glutathione are expressed as the percent of the content of cells incubated with A23187 alone.
RESULTS

A23187-induced
AA metabolism. Macrophages were incubated for 30 min with 10 PM A23187 alone (A), or A23187 in the presence of AF at 1.5 pg/ml (B), 3 pgg/ml (C), or 10 pg/ml (D). Retention times of authentic standards are indicated by arrows.
Alveolar macrophages (2 x 106) were incubated for 30 min in the presence or absence of 10 PM A23187, and eicosanoids were quantitated in medium by RIA. Each value is the mean 2 SE of three individual experiments, each performed in duplicate.
for LTB4, S-HETE, and free AA. Additional smaller peaks co-eluted with the lipoxygenase products LTCl and lZHETE, as well as the cyclooxygenase metabolites TxB2, PGE2, PGD2, and HI-IT. The eicosanoids LTC4, LTB4, and TxB2 were quantitated in unstimulated and A23187-stimulated cultures by RIA. and the mean values (N = 3) are summarized in Table 1 .
Effects of AF on A23187-induced AA metabolism. The effects of 1.5, 3, and lOpg/mi AF on A23187-induced macrophage AA metabolism are shown in the radioactivity RP-HPLC elution profiles depicted in Fig. 1 , panels B, C, and D respectively. Ionophoreinduced LTC4 synthesis was eliminated at 1.5 pg/ ml AF, while A23187-induced LTB4 and 5-HETE synthesis were inhibited in parallel fashion by AF over the concentration range 1.5 to lOpg/ml. In contrast, at all doses tested, AF augmented A23187-induced release of free AA as well as the cyclooxygenase products TxBz and HHT. That this increase in radioactivity in AA, TxB*, and HHT represents augmented phospholipase activity and not merely a shunting of [14C]arachidonate away from the 5-lipoxygenase pathway is suggested by the greater total release of radiolabeled AA plus metabolites in cultures containing AF.
To assess in a more quantitative fashion the effects of AF on AM arachidonate metabolism, unlabeled cultures were incubated with lO@l A23187 in the presence and absence of various concentrations of AF and eicosanoids measured by RIA. As shown in Fig. 2 , AF dose-dependently inhibited LTC4 (IC,, -1 &ml, ~90% inhibition at 5 pg/ml) with greater potency than LTB, (1~~~ -4.3 fig/ml , >90% inhibition at 10 pg/ml). AF dose-dependently augmented A23187-induced TxB2 synthesis by as much as 5-fold over the same concentration range at which it inhibited LT synthesis (Fig. 2) . Thus, both RP- HPLC and RIA experiments demonstrated that AF:
(1) inhibited LT synthesis while augmenting AA release and cyclooxygenase metabolism; and (2) inhibited the synthesis of LTC, with greater potency than other 5-lipoxygenase eicosanoids. Effects of AF on macrophage A TP content. Using the luciferase/luciferin method, we determined the ATP content of cells following 30 min of incubation with lO@M A23187 in the presence and absence of various concentrations of AF. The effects of AF on cellular ATP levels were determined relative to the ATP content of AM cultures containing A23187 alone both to duplicate the conditions under which eicosanoid levels were evaluated and because we have observed previously an independent ATPdepleting effect for A23187 1191. In the current study, the ATP content of AM cultures incubated with A23187 alone in the absence of AF was 269 +-77 pmoI/plate (N = 3). As shown in Fig. 3 AF effected a dose-dependent depletion of cellular ATP, with an 1c5c -5.9 pg/ml. To evaluate the potential for AF to interfere with the luciferase/ luciferin assay itself, different concentrations of AF were added directly to the assay buffer and ATP standard curves were generated.
At final AF concentrations G 10 pg/ml the gold compound had no effects on the ATP assay. Substantial interference with the measurement of ATP was observed at final AF ~ncentrations > 10 pg,/ml, however (data not shown).
Effects of AF on macruphage gIutath~one content.
To examine the possibility that the preferential inhibition by AF of LTCl synthesis, as compared to LTB4 synthesis, was related to its ability to conjugate reduced glutathione, thereby decreasing the amount available for LTC4 synthesis [24], we measured total glutathione levels in AM cultures. The glutathione content following 30 min of incubation with A23187 in the absence of AF was 369 ? 80 pmol/plate (N = 3). Auranofin exposure depleted cellular glutathione in a dose-dependent fashion, albeit with a potency far less than that observed for the inhibition of LTC, synthesis by AF; the Q for glutathione was -8 Fg/ ml, and 90% depletion was achieved at an AF concentration between 50 and lOOpg/ml (N = 3) (Fig.  4) .
DISCUSSION
Although other investigators have examined the effects of AF on LT synthesis in several different cell types [8-lo] , no information is available regarding its effects on the synthesis of LT and other oxygenated metabolites of AA by macrophages. Yet this issue is particularly germane to understanding the antiinflammatory actions of AF, for the following reasons: (1) macrophages are thought to play a key role in the pathogenesis of chronic inffammatory disorders such as rheumatoid arthritis and asthma
[ll]; (2) the macrophage is generally regarded as an important target cell for the effects of chrysotherapy [ 131; and (3) as compared to most other inflammatory cells, including the neutrophil, the macrophage has the capacity to synthesize larger quantities [25] as well as a more diverse spectrum of eicosanoids, including both LX, and LTB., as well as a variety of cyclooxygenase metabolites [12] . We therefore undertook the present study to examine comprehensively the modulatory effects of AF on AA metabolism by the rat AM, a cell whose profile of eicosanoid synthesis appears to closely resemble that of the human AM [26] . Ionophore A23187 was selected as an agonist because it is a potent stimulus for arachidonate metabolism via both cyclooxygenase and lipoxygenase pathways which bypasses the need for specific receptor interactions; as such, it can be regarded as a maximal stimulus of AA metabolism
1271.
Analysis by RP-HPLC of the eicosanoid products of prelabeled AM indicated that A23187 stimulated the release of free AA and its metabolism to S-lipoxygenase products (LTB, > 5-HETE > LTC.+) to a greater extent than cyclooxygenase products (HHT = TxB2 = PGDz > PGEz). Auranofin caused a parallel inhibition of both LTB4 and 5-HETE synthesis by AM. This suggests that its inhibitory site of action was the 5lipoxygenase enzyme itself, consistent with the findings of Honda and coworkers for intact neutrophils as well as cell-free homogenates [9] . Also in agreement with other reports [8, 9] , AF inhibited A23187-induced LTCl synthesis (IC& -1 fig/ml) with greater potency than that observed for LTB4 synthesis (K& -4.3 pg/ml), as revealed by both RP-HPLC and RIA analyses. The concentrations of AF at which we observed inhibition of LT synthesis are within the ranges reported by other investigators in blood neutrophils [8, 9] as well as basophils and lung mast cells [lo] . In addition, as therapeutic AF concentrations in blood are in the 2-3 pug/ml range [28] , and as gold has been shown to concentrate in macrophages at inflammatory sites [29] , including alveolar macrophages 1301, it is likely that the AF concentrations required for inhibition of LTC4, as well as LTB4, synthesis in the present study can be achieved locally at sites of inflammation in vivo.
It is important to note that the inhibitory effects of AF in our system were specific for the 5lipoxygenase pathway; the cyclooxygenase pathway, as assessed by both RIA and RP-HPLC quantitation of TxB2, the major cyclooxygenase metabolite of the rat AM [14], was spared. Such specificity is consistent with the findings of Parente et al. [8] that AF inhibits neutrophil synthesis of LT, but not PGEr. In fact, our data indicated that A23187-induced TxBr synthesis was augmented over the same concentration range at which LT synthesis was inhibited. Analysis by RP-HPLC of the total products of prelabeled cells suggests that this refIects an actual au~entation of total phospholipase activity by AF, rather than mere shunting away from the 5lipoxygenase pathway. In this regard, it is relevant that AF has been shown recently to stimulate phospholipase C activity in sonicates of a murine macrophage-like cell line [31] .
ATP is a cofactor for 5-lipoxygenase [U, 161, and we have reported recently that ATP depletion accounts for the inhibition of AM 5-lipoxygenase caused by both unsaturated fatty acids [19] and hydrogen peroxide 1321. Because AF is thought to interfere with ~tochond~al unctions 1331, we considered the possibility that an ATP-depleting effect may similarly play a role in its inhibition of 5-lipoxygenase. Our data suggest such a possibility, as the IC~~ for ATP depletion was similar to that for LTBq synthesis inhibition. A definitive causal link between the capacities of AF to inhibit Nipoxygenase and deplete cellular ATP remains to be established, however. We speculate that ATP depletion may also play a role in the cytotoxicity and alterations in plasma membrane morphology attributed to AF [33] .
We next considered the possibility that the preferential inhibition by AF of macrophage LTC,+, as opposed to LTB4 and 5-HETE synthesis, may be related to the capacity to conjugate reduced glutathione based on its sulfhydryl reactivity [33] . We have demonstrated previously [14] that the sulfhydryl reactant N-ethylmaleimide depletes AM glutathione with the consequence that synthesis of LTC,, which is formed by the glutathione transferase-catalyzed conjugation of reduced glutathione and LTA,, is specifically inhibited. Our results demonstrated that AF did indeed deplete cellular glutathione, but the dose-response relationships for glutathione depletion and LTCl inhibition suggest that these two phenomena were not causally related. A likely alternative explanation for the preferential in~bition of LTC4 synthesis is the higher Km value for LTA4 of glutathione transferase (catalyzing LTC4 synthesis) than of LTAl hydrolase (catalyzing LTB4 synthesis) [9] . The consequence of such a difference in K,,, values would be that, as LTA4 levels decline due to S-lipoxygenase inhibition, LTC4 synthesis would be more susceptible to substrate limitation than would LTB4 synthesis. In accord with this possibility, we have observed a similar preferential inhibition of LTC., versus LTBd synthesis in the settings of 5-lipoxygenase inhibition caused by both unsaturated fatty acids [19] and hydrogen peroxide [32] . Leukotriene C4 increases microvascular permeability, while LTB4 is a leukocyte chemoattractant which also stimulates leukocyte adherence and activation as well as modulating lymphocyte proliferation, differentiation, and function [7] . In addition, of particular relevance to the pathogenesis of asthma are the capacities of LTB, to increase airway reactivity 1341 and of LTC, to cause bronchoconstriction [35] and stimulate mucus secretion in airways 1361. Our results indicate that, at therapeutic concentrations, AF, an oral gold compound approved for use in the United States, acts in vitro as a selective inhibitor of macrophage 5-lipoxygenase metabolism. For all of these reasons, it is likely that inhibition of macrophage LT synthesis represents an important mechanism of action of AF in chronic in~ammatory disorders such as rheumatoid arthritis and asthma.
